Divi's Laboratories Ltd
NSE:DIVISLAB

Watchlist Manager
Divi's Laboratories Ltd Logo
Divi's Laboratories Ltd
NSE:DIVISLAB
Watchlist
Price: 6 906.5 INR 0.44% Market Closed
Market Cap: 1.8T INR
Section:
Profitability Summary
Profitability Summary
Past Growth
Margins
Return on Capital
Free Cash Flow
See Also

Profitability Summary

Divi's Laboratories Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less
0
Revenue
+0%
3Y
+3%
5Y
+71%
10Y
+1 021%
0
Operating Income
+0%
3Y
-28%
5Y
+57%
10Y
+839%
0
Net Income
+0%
3Y
-25%
5Y
+60%
10Y
+854%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Divi's Laboratories Ltd

Revenue
92B INR
Cost of Revenue
-36.8B INR
Gross Profit
55.2B INR
Operating Expenses
-29.4B INR
Operating Income
25.8B INR
Other Expenses
-3.7B INR
Net Income
22.1B INR

Margins Comparison
Divi's Laboratories Ltd Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
IN
Divi's Laboratories Ltd
NSE:DIVISLAB
1.8T INR
60%
28%
24%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
56%
15%
10%
US
Thermo Fisher Scientific Inc
NYSE:TMO
162.1B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
145.4B USD
60%
22%
16%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
53%
32%
26%
CH
Lonza Group AG
SIX:LONN
39.1B CHF
37%
18%
10%
US
Agilent Technologies Inc
NYSE:A
34.5B USD
54%
23%
18%
US
IQVIA Holdings Inc
NYSE:IQV
28.6B USD
35%
15%
9%
CN
WuXi AppTec Co Ltd
SSE:603259
204.5B CNY
42%
27%
27%
US
Mettler-Toledo International Inc
NYSE:MTD
25.1B USD
60%
29%
22%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
44%
14%
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Divi's Laboratories Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Divi's Laboratories Ltd
NSE:DIVISLAB
1.8T INR
16%
14%
18%
15%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
4%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
162.1B USD
14%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
145.4B USD
7%
5%
7%
6%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
12%
8%
12%
8%
CH
Lonza Group AG
SIX:LONN
39.1B CHF
7%
4%
8%
6%
US
Agilent Technologies Inc
NYSE:A
34.5B USD
19%
10%
16%
14%
US
IQVIA Holdings Inc
NYSE:IQV
28.6B USD
22%
5%
11%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
204.5B CNY
20%
14%
17%
16%
US
Mettler-Toledo International Inc
NYSE:MTD
25.1B USD
-499%
26%
52%
31%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
5%
2%
5%
4%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less

See Also

Summary
DIVISLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
DIVISLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DIVISLAB stock valuation using valuation multiples.
Wall Street Estimates
DIVISLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DIVISLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 265,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.